- Home
- ALLK vs DERM Comparison
ALLK vs DERM Comparison
Compare ALLK & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- DERM
- Stock Information
- Founded
- ALLK 2012
- DERM 2014
- Country
- ALLK United States
- DERM United States
- Employees
- ALLK N/A
- DERM N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- ALLK Health Care
- DERM Health Care
- Exchange
- ALLK Nasdaq
- DERM Nasdaq
- Market Cap
- ALLK 22.5M
- DERM 95.0M
- IPO Year
- ALLK 2018
- DERM 2021
- Fundamental
- Price
- ALLK $0.25
- DERM $5.35
- Analyst Decision
- ALLK Hold
- DERM Strong Buy
- Analyst Count
- ALLK 3
- DERM 3
- Target Price
- ALLK $2.00
- DERM $9.50
- AVG Volume (30 Days)
- ALLK 4.8M
- DERM 54.1K
- Earning Date
- ALLK 03-13-2025
- DERM 03-20-2025
- Dividend Yield
- ALLK N/A
- DERM N/A
- EPS Growth
- ALLK N/A
- DERM N/A
- EPS
- ALLK N/A
- DERM N/A
- Revenue
- ALLK N/A
- DERM $57,771,000.00
- Revenue This Year
- ALLK N/A
- DERM N/A
- Revenue Next Year
- ALLK N/A
- DERM $36.49
- P/E Ratio
- ALLK N/A
- DERM N/A
- Revenue Growth
- ALLK N/A
- DERM N/A
- 52 Week Low
- ALLK $0.23
- DERM $2.85
- 52 Week High
- ALLK $1.69
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- ALLK 28.77
- DERM 65.80
- Support Level
- ALLK $0.23
- DERM $3.86
- Resistance Level
- ALLK $0.26
- DERM $5.03
- Average True Range (ATR)
- ALLK 0.11
- DERM 0.31
- MACD
- ALLK -0.08
- DERM 0.17
- Stochastic Oscillator
- ALLK 1.62
- DERM 94.28
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.